Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 439-590-3 | CAS number: 12158-75-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity: 500 < LD50 < 1000 mg/Kg/bw.
Acute inhalation toxicity: No study available.
Acute dermal toxicity: LD50 > 2000 mg/Kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from March 13, 2001 to March 29, 2001
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study (OECD).
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Crl: CD (SD) IGS BR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- hygiene: optimal hygienic conditions
room temperature: average of 22.5°C (continuous control and recording)
relative humidity: average of 49.9% (continuous control and recording)
air exchange: 12 per hour
light: artificial light from 6 a.m. to 6 p.m.
cages: single caging in Makrolon cages type III ; wire mesh lids ; sanitation of cages once a week
bedding material: aspen wood chips, type "4 HV", autoclaved ; the bedding material was changed weekly
environmental enrichment: nibbling wood bricks and nesting material, both from the same material and source as the bedding material, were offered to the animals once a week
feed: Altromin 1324 forte, gamma irradiated with 25 kGy 60Co, ad libitum (producer: Altromin GmbH, D-32761 Lage) ; exception: the feed was withdrawn the evening before the administration of the test substance and was offered again about 3 hours afterwards ; random samples of the feed are analysed for contaminants by Altromin
water: tap water from an automatic watering system, ad libitum
identification: labelling with felt-tipped pen on the tail and on the cage
acclimatisation: at least 5 days - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- The test substance was dissolved in deionised water.
The solutions were prepared freshly before administration and were administered within 10 minutes after the preparation.
A peroral administraiton was performed once in the morning by stomach intubation using a metal gavage. - Doses:
- 200 (male/female) & 2000 (male) mg per kg body weight
The dose volume was 20 mL per kg body weight. The individual dose volumes were calculating using the body weights determined at the day of administration. - No. of animals per sex per dose:
- 3 (in dose groups)
- Control animals:
- no
- Details on study design:
- Observations were performed within the periods 0-0.5, 0.5-1, 2-4 and 4-6 hours after administration (p.a.) of the test substance and then at least once a day for a total of 2 weeks. Observations included but were not limited to changes in skin, fur, eyes, the occurence of secretions and excretions, automatic activity, changes in gait, posture and the presence of convulsions.
Body weights were determined before administration, 7 days p.a., 14 days p.a., early deaths as soon as possible after fnding. Body weight gains were calculated for each week of the study, i.e. 0-7 days p.a. and 7-14 days p.a.
Deceased animals were dissected and examined macroscopically in an attempt to identify the target organs. Surviving animals were killed by CO2-asphyxia 14 days p.a. and subjected to a necropsy including a gross pathological examination. - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 500 - < 1 000 mg/kg bw
- Mortality:
- 200 mg/kg b.w., males: all animals survived until the scheduled termination of the study.
200 mg/kg b.w., females: all animals survived until the scheduled termination of the study.
2000 mg/kg b.w., males: 2/3 animals died on the day of administration. - Clinical signs:
- other: Only the high dose males were affected. The findings, with an onset shortly after administration and lasing until death or to a maximum of 10 d.p.a. were: - autonomous nervous effects: piloerection - central nervous effects: sedation - signs of discomfort
- Gross pathology:
- See 'Remarks on results' section.
- Other findings:
- Necropsy findings:
Anormal findings were present only in deceased animals: swelling of the gastric and intestinal mucosa, irritation of the trachea. tracheal irritation may be due to a minimum test substance reflux, but was not expressed enough to have been cause of death.
All other animalswere normal at the necropsy 14 d.p.a. - Interpretation of results:
- harmful
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of this study, the oral LD50 for Basic Copper Nitrate was estimated to be higher than 500 and less than 1000 mg/ Kg bw in rats.
According to the EC Regulation No. 1272/2008 and subsequent regulations, Basic Copper Nitrate is classified as acutely toxic by oral route - category 4.
Reference
Synopsis of the results - time of death:
dose (mg/Kg) | sex | animal n° | nb. of animals | time of death | ||
exposed | affected | deceased | ||||
200 | m | 71 - 73 | 3 | 0 | 0 | animals survived |
200 | f | 76 - 78 | 3 | 0 | 0 | animals survived |
2000 | m | 81 | 3 | 3 | 2 | between 2 and 4 hours |
82 | animal survived | |||||
83 | between 2 and 4 hours |
Body weights and body weight gains:
Dose | Animal n° |
Body weight (g) |
Body weight gain (g) |
||||
Sex | before administration | 7 days p.a. | 14 days p.a. | death | 0-7 days p.a. | 7-14 days p.a. | |
200 mg/Kg m | 71 | 209 | 293 | 338 | - | 84 | 45 |
72 | 206 | 264 | 288 | - | 58 | 24 | |
73 | 208 | 289 | 333 | - | 81 | 44 | |
mean | 208 | 282 | 320 | - | 74 | 38 | |
SD | 2 | 16 | 28 | - | 14 | 12 | |
200 mg/Kg f | 76 | 168 | 195 | 200 | - | 27 | 5 |
77 | 170 | 207 | 233 | - | 37 | 26 | |
78 | 180 | 229 | 246 | - | 49 | 17 | |
mean | 173 | 210 | 226 | - | 38 | 16 | |
SD | 6 | 17 | 24 | - | 11 | 11 | |
2000 mg/Kg m | 81 | 213 | a) | a) | - | a) | a) |
82 | 209 | 212 | 273 | - | 3 | 61 | |
83 | 221 | a) | a) | - | a) | a) | |
mean | 214 | - | - | - | - | - | |
SD | 6 | - | - | - | - | - |
a) animal died spontaneously.
Observations in life:
'low-mid-high': grade of severity was recorded (where applicable).
'-': no grade of severity applicable.
Findings | Dose (mg/Kg), sex | N° of affected animals | Observation time (p.a.) first - last | Maximum grade of severity |
Piloerection | 2000, M | 81 (a) | 0,5h - 2h (b) | - |
82 | 0,5h - 1 d | - | ||
83 (a) | 0,5h - 2h (b) | - | ||
Closed eyes | 2000, M | 81 (a) | 1h - 2h (b) | - |
83 (a) | 1h - 2h (b) | - | ||
Chromodacryorrhoea | 2000, M | 82 | 2d - 8d | low |
Anaemia, pale skin | 2000, M | 82 | 6d - 9d | - |
Hunched posture | 2000, M | 81 (a) | 2h (b) | - |
82 | 6h - 10d | - | ||
Sedation | 2000, M | 81 (a) | 1 - 2h (b) | mid |
82 | 1h - 7 d | mid | ||
83 (a) | 1 - 2h (b) | mid | ||
Normal at any time | 200, M | 71 | - | - |
72 | - | - | ||
73 | - | - | ||
200, F | 76 | - | - | |
77 | - | - | ||
78 | - | - |
(a) animal died spontaneously
(b) sign did not resolved before death
Necropsy findings:
Number of animals examined = 3 females and 6 males.
SYSTEM | Dose | Sex | N° of affected animals |
organ, finding | (mg/kg) | ||
normal | 200 | m | 71, 72, 73 |
200 | f | 76,77,78 | |
2000 | m | 82 | |
ALIMENTARY SYSTEM | |||
glandular stomach, mucosa, swelling | 2000 | m | 81 (a), 83 (a) |
intestinum, mucosa, swelling | 2000 | m | 81 (a), 83 (a) |
RESPIRATORY SYSTEM | |||
trachea, local irritation | 2000 | m | 81 (a) |
(a) animal died spontaneously.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from March 13, 2001 to April 10, 2001
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study (OECD).
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Crl: CD (SD) IGS BR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- hygiene: optimal hygienic conditions
room temperature: average of 21.6°C (continuous control and recording)
relative humidity: average of 62.4% (continuous control and recording)
air exchange: 12 per hour
light: artificial light from 6 a.m. to 6 p.m.
cages: single caging in Makrolon cages type III ; wire mesh lids ; sanitation of cages once a week
bedding material: aspen wood chips, type "4 HV", autoclaved ; the bedding material was changed weekly
environmental enrichment: nibbling wood bricks and nesting material, both from the same material and source as the bedding material, were offered to the animals once a week
feed: Altromin 1324 forte, gamma irradiated with 25 kGy 60Co, ad libitum (producer: Altromin GmbH, D-32761 Lage) ; random samples of the feed are analysed for contaminants by Altromin
water: tap water from an automatic watering system, ad libitum
identification: labelling with felt-tipped pen on the tail and on the cage
acclimatisation: at least 5 days - Type of coverage:
- semiocclusive
- Vehicle:
- other: soaked with deionised water
- Details on dermal exposure:
- Hair of the dorsal trunk was clipped with an electrical hair clipper one day before the application of the test substance. The test site was located on the median dorsal thoracal region.
A dermal administration was performed once by spreading the test substance on an area of about 10% of the estimated body surface. An area of 5 cm x 6 cm was labelled in a relaxed animal. This area, when stretched for administration, gives an application site of about 50 cm².
A cellulose patch with the calculated amount of the test substance, spread over an area of approximately 5 cm x 6 cm and soaked with deionised water to get optimal contact with the skin, was applied to the test site and held in place by fixing marginally with non irritating tape. Patch and tape were covered semi-occlusively by a dressing.
At the end of the exposure period, the dressing, the tape and the patch were removed. Residual test substance was wopped off using a cellulose tissue. - Duration of exposure:
- 24 hours
- Doses:
- 2000 (male/female) mg per kg body weight
The individual dose volumes were calculating using the body weights determined at the day of administration. - No. of animals per sex per dose:
- 5 (in dose groups)
- Control animals:
- no
- Details on study design:
- Observations were performed within the periods 0-0.5, 0.5-1, 2-4 and 4-6 hours after administration (p.a.) of the test substance and then at least once a day for a total of 2 weeks. Observations included but were not limited to changes in skin, fur, eyes, the occurence of secretions and excretions, automatic activity, changes in gait, posture and the presence of convulsions.
- Preliminary study:
- In a range finding study 3 groups of one male and one female each were dosed with 400 or 894 or 2000 mg per kg body weight. All animals survived until 7d.p.a. Therefore a limit test with one dose of 2000 mg per kg body weight was performed.
Both animals, dosed with 2000 mg/kg body weight in the preliminary test, were included into the main study. - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- All animals survived until the scheduled termination of the study.
- Clinical signs:
- other: All animals were affected. The findings in life were: - signs of discomfort: chromodacryorrhoea - other effects: staining of the skin at the application site ; This discoloration is directly attributed to a staining property of the test substance ans is n
- Gross pathology:
- See 'Remarks on results' section.
- Other findings:
- Necropsy findings:
No abnormal findings were made post mortem. - Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of this study, the dermal LD50 for Basic Copper Nitrate was estimated to be higher than 2000 mg/ Kg bw in rats.
According to the EC Regulation No. 1272/2008 and subsequent regulations, Basic Copper Nitrate is not classified as acutely toxic by dermal route.
Reference
Synopsis of the results:
Main study:
Sex | Animal n° | Dose (mg/Kg) | Number of animals | ||
exposed | affected | deceased | |||
m | 321-325 | 2000 | 5 | 5 | 0 |
f | 326-330 | 2000 | 5 | 5 | 0 |
Range finding study:
Sex | Animal n° | Dose (mg/Kg) | Number of animals | ||
exposed | affected | deceased | |||
m | 301 | 400 | 1 | 1 | 0 |
f | 306 | 400 | 1 | 1 | 0 |
m | 311 | 894 | 1 | 1 | 0 |
f | 316 | 894 | 1 | 1 | 0 |
m | 321 | 2000 | 1 | 1 | 0 |
f | 326 | 2000 | 1 | 1 | 0 |
Body weight and body weight gain:
Dose | Animal n° | Body weight (g) | Body weight gain (g) | ||||
Sex | before administration | 7 days p.a. | 14 days p.a. | death | 0-7 days p.a. | 7-14 days p.a. | |
200o mg/Kg m | 321 | 294 | 322 | 356 | - | 28 | 34 |
322 | 271 | 317 | 369 | - | 46 | 52 | |
323 | 278 | 330 | 378 | - | 52 | 48 | |
324 | 292 | 332 | 380 | - | 40 | 48 | |
325 | 293 | 347 | 391 | - | 54 | 44 | |
mean | 286 | 330 | 375 | - | 44 | 45 | |
SD | 10 | 11 | 13 | - | 10 | 7 | |
2000 mg/Kg m | 326 | 253 | 254 | 279 | - | 1 | 25 |
327 | 231 | 234 | 246 | - | 3 | 12 | |
328 | 236 | 239 | 245 | - | 3 | 6 | |
329 | 228 | 230 | 248 | - | 2 | 18 | |
330 | 234 | 252 | 261 | - | 18 | 9 | |
mean | 236 | 242 | 256 | - | 5 | 14 | |
SD | 10 | 11 | 14 | - | 7 | 8 |
Observations in life:
'low-mid-high': grade of severity was recorded (where applicable).
'-': no grade of severity applicable.
Findings | Dose (mg/Kg), sex | N° of affected animals | Observation time (p.a.) first - last | Maximum grade of severity |
Chromodacryorrhoea | 2000, M | 321 | 6h - 1d | low |
2000, F | 327 | 0,5h - 6h | low | |
Test substance related stain of skin | 2000, M | 321 | 1d - 3d | - |
322 | 1d - 3d | - | ||
323 | 1d - 4d | - | ||
324 | 1d - 3d | - | ||
325 | 1d - 4d | - | ||
2000, F | 326 | 1d - 4d | - | |
327 | 1d - 3d | - | ||
328 | 1d - 2d | - | ||
329 | 1d - 3d | - | ||
330 | 1d - 2d | - |
Necropsy findings:
Number of animals examined: 5 males and 5 females
SYSTEM | Dose | Sex | N° of affected animals |
organ, finding | (mg/kg) | ||
normal | 2000 | m | 321, 322, 323, 324, 325 |
2000 | f | 326, 327, 328, 329, 330 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Acute toxicity by oral route:
Under the conditions of the study, the oral LD50 for Basic Copper Nitrate was estimated to be higher than 500 and less than 1000 mg/ Kg bw in rats.
According to the EC Regulation No. 1272/2008 and subsequent regulations, Basic Copper Nitrate is classified as acutely toxic by oral route - category 4.
Acute toxicity by inhalation route:
No study available.
Acute toxicity dermal:
Under the conditions of this study, the dermal LD50 for Basic Copper Nitrate was estimated to be higher than 2000 mg/ Kg bw in rats.
According to the EC Regulation No. 1272/2008 and subsequent regulations, Basic Copper Nitrate is not classified as acutely toxic by dermal route.
Justification for selection of acute toxicity – oral endpoint
OECD test guideline - LD50 was determined to be higher than 500 and less than 100 mg/Kg bw.
Justification for selection of acute toxicity – dermal endpoint
OECD test guideline - LD50 was determined to be higher than 2000 mg/Kg bw.
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.